Our team will assist you in verifying your benefits so you have a clear understanding of any potential costs
Author: Shelley Jeon, PharmD Candidate 2025, Northeastern University School of Pharmacy Reviewer: Courtney Cameron, PharmD, BCACP What data are available on weight regain after stopping GLP-1 receptor agonists
Your healthcare provider will start you on a lower dose of semaglutide GLP-1 to minimize potential side effects like nausea or stomach discomfort
Semaglutide represents the superior choice for patients seeking maximum weight loss efficacy and who can tolerate gastrointestinal side effects during the initial months of treatment
This guide is for patients using or considering GLP-1 medications for weight loss, including semaglutide or tirzepatide, who want to understand which side effects are common and which symptoms should lead to a call with a physician
On average, patients return to their pre-treatment weight within 1.7 years of stopping any weight management medication, including semaglutide and tirzepatide